首页> 美国卫生研究院文献>Journal of Pain Research >Damaging State Legislation Regarding Opioids: The Need To Scrutinize Sources Of Inaccurate Information Provided To Lawmakers
【2h】

Damaging State Legislation Regarding Opioids: The Need To Scrutinize Sources Of Inaccurate Information Provided To Lawmakers

机译:关于阿片类药物的国家立法受到破坏:需要仔细研究提供给立法者的不正确信息的来源

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

On January 22, 2019, a Massachusetts State Representative introduced House Bill 3656, “An Act requiring practitioners to be held responsible for patient opioid addiction”. Section 50 of this proposed legislation reads, “A practitioner, who issues a prescription for a controlled substance placed in Schedule II, which contains an opiate, shall be liable to the patient for whom the written prescription was written, for the payment of the first 90 days of in-patient hospitalization costs if the patient becomes addicted and is subsequently hospitalized”. The bill was assigned to a joint House/Senate committee, and the Representative testified in a hearing of the Joint Commission of the Judiciary on September 17, 2019. According to the Representative, the Joint Commission “didn’t vote on it, and I don’t suspect it will ever get a vote”. After speaking to him, he acknowledged that the bill would not be resurrected. When asked of the source of medical information on which he based his bill, the Representative mentioned the name of a nationally known addiction psychiatrist. Unfortunately, this psychiatrist, to the best of our knowledge, had no training or clinical experience in treating chronic pain, nor has he published research on the topic area.
机译:2019年1月22日,马萨诸塞州州代表介绍了第3656号众议院法案,“该法案要求从业人员对患者阿片类药物成瘾负责。”该拟议法律的第50条规定:“从业人员开具附表II中包含鸦片制剂的受控物质处方,应向为其写有书面处方的患者承担首笔付款的责任。如果患者上瘾并随后住院,则需要90天的住院治疗费用”。该法案已分配给参议院/参议院联合委员会,并且该代表于2019年9月17日在司法机构联合委员会的听证会上作证。根据该代表,联合委员会“未对此进行表决,我不要怀疑它将获得投票。”在与他交谈后,他承认该法案将不会复活。当被问及他的帐单所依据的医疗信息的来源时,该代表提到了一位全国上瘾的精神病医生的名字。不幸的是,就我们所知,这位精神科医生没有接受过治疗或治疗慢性疼痛的临床经验,也没有发表有关该领域的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号